Gossamer Bio Inc (GOSS)

May 22, 2025

Cantor Fitzgerald Forecasts Gossamer Bio FY2025 Earnings - Defense World

May 22, 2025

May 20, 2025

Analyze Gossamer Bio Inc (NASDAQ: GOSS) Before Investing. - Stocksregister

May 20, 2025

May 19, 2025

Price T Rowe Associates Inc. MD Has $59,000 Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

May 19, 2025

May 18, 2025

Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript - MSN

May 18, 2025

May 18, 2025

Wedbush Reiterates “Outperform” Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World

May 18, 2025

May 18, 2025

The Goldman Sachs Group Raises Gossamer Bio (NASDAQ:GOSS) Price Target to $8.00 - Defense World

May 18, 2025

May 17, 2025

GOSS Stock Update: Analyst Reiterates Outperform Rating | GOSS S - GuruFocus

May 17, 2025

May 16, 2025

Gossamer Bio’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

May 16, 2025

May 16, 2025

Gossamer Bio (GOSS): Goldman Sachs Raises Price Target to $8.00 - GuruFocus

May 16, 2025

May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Cantor Fitzgerald maintains Overweight on Gossamer Bio stock - Investing.com

May 16, 2025

May 16, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Gossamer Bio: Q1 Earnings Snapshot - CT Insider

May 16, 2025

May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strategic Progress Amid Financial ... - Yahoo Finance

May 16, 2025

May 16, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings Call Highlights: Strate - GuruFocus

May 16, 2025

May 15, 2025

Transcript : Gossamer Bio, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025

May 15, 2025

Earnings call transcript: Gossamer Bio exceeds Q1 2025 revenue forecasts - Investing.com Australia

May 15, 2025

May 15, 2025

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 15, 2025

May 15, 2025

Gossamer Bio earnings beat by $0.03, revenue topped estimates - Investing.com

May 15, 2025

May 15, 2025

Gossamer Bio Inc (GOSS) Q1 2025 Earnings: EPS Loss of $0.16 Beats Estimate, Revenue Surges to $9.9 Million - GuruFocus

May 15, 2025

May 15, 2025

GOSSAMER BIO Earnings Results: $GOSS Reports Quarterly Earnings - Nasdaq

May 15, 2025

May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key St - GuruFocus

May 15, 2025

May 15, 2025

Gossamer Bio (GOSS) Surpasses Revenue Estimates, Advances Key Studies | GOSS Stock News - GuruFocus

May 15, 2025

May 15, 2025

Gossamer Bio, Inc. SEC 10-Q Report - TradingView

May 15, 2025

May 15, 2025

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study - Eagle-Tribune

May 15, 2025

May 15, 2025

Gossamer Bio Q1 2025 Earnings Call Transcript - MarketBeat

May 15, 2025

May 14, 2025

What To Expect From Gossamer Bio Inc (GOSS) Q1 2025 Earnings - GuruFocus

May 14, 2025

May 12, 2025

Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025 - Eagle-Tribune

May 12, 2025

May 08, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 7, 2025 - BioSpace

May 08, 2025

May 07, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rul - GuruFocus

May 07, 2025

May 07, 2025

Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference - The Joplin Globe

May 07, 2025

May 07, 2025

Market Highlights: Gossamer Bio Inc (GOSS) Ends on a Low Note at 1.09 - DWinneX

May 07, 2025

May 05, 2025

Gossamer Bio Inc: Is GOSS Stock Worth Buying? - Stocksregister

May 05, 2025

May 04, 2025

Gossamer Bio (GOSS) Expected to Announce Earnings on Tuesday - Defense World

May 04, 2025

May 02, 2025

Gossamer Bio: Initiating Hold As Late‐Stage Data Nears Inflection (GOSS) - Seeking Alpha

May 02, 2025

May 01, 2025

Selling Buzz: Gossamer Bio Inc [GOSS] Chief Medical Officer Aranda Richard sells 1,908 shares of the company - knoxdaily.com

May 01, 2025

Apr 30, 2025

Check out these key findings about Gossamer Bio Inc (GOSS) - Sete News

Apr 30, 2025

Apr 30, 2025

Geode Capital Management LLC Has $2.04 Million Stock Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Apr 30, 2025

Apr 29, 2025

Was Gossamer Bio Inc (GOSS)’s session last reading good? - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Gossamer Bio Inc (GOSS) Stock: A Year of Declines and Increases - investchronicle.com

Apr 29, 2025

Apr 28, 2025

Closing Strong: Gossamer Bio Inc (GOSS) Ends at 1.17, Up 0.86 from Last Close - DWinneX

Apr 28, 2025

Apr 28, 2025

Monitoring Gossamer Bio Inc (GOSS) after recent insider movements - knoxdaily.com

Apr 28, 2025

Apr 25, 2025

Gossamer Bio Inc (GOSS Stock: A Sea of Opportunity - investchronicle.com

Apr 25, 2025

Apr 25, 2025

Gossamer Bio Insider Confidence Rewarded, Stock Hits US$203m Market Cap - simplywall.st

Apr 25, 2025

Apr 25, 2025

3 Promising Penny Stocks With Market Caps Over $100M - simplywall.st

Apr 25, 2025

Apr 24, 2025

Taking the lead: Gossamer Bio Inc (GOSS) - Sete News

Apr 24, 2025

Apr 23, 2025

Oppenheimer initates Gossamer Bio Inc (GOSS) rating to an Outperform - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

GOSS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com

Apr 23, 2025

Apr 23, 2025

Stock Performance Spotlight: Gossamer Bio Inc (GOSS) Ends the Day at 0.83, Up by 1.77 - DWinneX

Apr 23, 2025

Apr 22, 2025

Pleasing Signs As A Number Of Insiders Buy Gossamer Bio Stock - Yahoo Finance

Apr 22, 2025

Apr 19, 2025

The Goldman Sachs Group Has Lowered Expectations for Gossamer Bio (NASDAQ:GOSS) Stock Price - Defense World

Apr 19, 2025

Apr 16, 2025

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1? - Insider Monkey

Apr 16, 2025